Analyst Ratings (USA)
Applied Aerospace & Defense (AADX) — Jefferies Financial Group downgraded the stock to Hold and revised its price target from $20.00 to $10.00.
Aardvark Therapeutics (AARD) — Stifel Nicolaus set a price target of $2.00.
AbbVie (ABBV) — Barclays raised its price target from $325.00 to $335.00, maintaining an Overweight rating.
Ameris Bancorp (ABCB) — Raymond James Financial maintained its Market Perform rating.
AbCellera Biologics (ABCL) — Jefferies Financial Group maintained its Buy rating.
AbCellera Biologics (ABCL) — Piper Sandler raised its price target from $12.00 to $20.00, maintaining an Overweight rating.
Airbnb (ABNB) — Phillip Securities upgraded the stock to Hold and revised its price target from $158.00 to $184.00.
Absci (ABSI) — Guggenheim lowered its price target from $15.00 to $14.00, maintaining a Buy rating.
Array Digital Infrastructure (AD) — Royal Bank Of Canada lowered its price target from $40.00 to $33.00, maintaining a Sector Perform rating.
Array Digital Infrastructure (AD) — JPMorgan Chase & Co. lowered its price target from $45.00 to $43.00, maintaining an Overweight rating.
Agree Realty (ADC) — Wells Fargo & Company raised its price target from $79.00 to $81.00, maintaining an Overweight rating.
ADI Global Distribution Inc. Common Stock (ADIG) — Truist Financial lowered its price target from $24.00 to $11.00, maintaining a Hold rating.
Addus HomeCare (ADUS) — Royal Bank Of Canada raised its price target from $134.00 to $141.00, maintaining an Outperform rating.
Aetherion Technologies (AETR) — Royal Bank Of Canada raised its price target from $1.00 to $1.75, maintaining a Sector Perform rating.
Assurant (AIZ) — Morgan Stanley raised its price target from $330.00 to $360.00, maintaining an Overweight rating.
Arthur J. Gallagher & Co. (AJG) — Morgan Stanley raised its price target from $295.00 to $325.00, maintaining an Overweight rating.
Akebia Therapeutics (AKBA) — Piper Sandler issued a price target of $2.00, maintaining an Overweight rating.
Allstate (ALL) — JPMorgan Chase & Co. lowered its price target from $292.00 to $291.00, maintaining an Overweight rating.
Alumis (ALMS) — Oppenheimer issued a price target of $28.00, maintaining an Outperform rating.
Applied Materials (AMAT) — Freedom Broker lowered its price target from $530.00 to $490.00, maintaining a Buy rating.
Applied Materials (AMAT) — Susquehanna maintained its Positive rating.
Amgen (AMGN) — Barclays raised its price target from $400.00 to $430.00, maintaining an Equal Weight rating.
Amrize (AMRZ) — Jefferies Financial Group downgraded the stock to Underperform and revised its price target from $42.80 to $35.20.
Amrize (AMRZ) — UBS Group raised its price target from $42.00 to $46.00, maintaining a Neutral rating.
Anika Therapeutics (ANIK) — B. Riley Financial maintained its Buy rating and revised its price target from $23.00 to $17.00.
Annovis Bio (ANVS) — Roth Capital maintained its Buy rating with a price target of $3.00.
AON (AON) — Morgan Stanley raised its price target from $350.00 to $385.00, maintaining an Overweight rating.
AppLovin (APP) — Jefferies Financial Group set a price target of $500.00, maintaining a Buy rating.
Alexandria Real Estate Equities (ARE) — Mizuho lowered its price target from $60.00 to $50.00, maintaining an Outperform rating.
argenex (ARGX) — Piper Sandler raised its price target from $1,215.00 to $1,350.00, maintaining an Overweight rating.
Ascendis Pharma A/S (ASND) — Barclays raised its price target from $329.00 to $341.00, maintaining an Overweight rating.
ArriVent BioPharma (AVBP) — Guggenheim lowered its price target from $30.00 to $28.00, maintaining a Buy rating.
Atea Pharmaceuticals (AVIR) — Morgan Stanley raised its price target from $7.00 to $8.00, maintaining an Equal Weight rating.
Avalyn Pharma (AVLN) — Morgan Stanley lowered its price target from $57.00 to $53.00, maintaining an Overweight rating.
American Water Works (AWK) — Bank of America set a price target of $157.00, maintaining a Neutral rating.
Credicorp (BAP) — JPMorgan Chase & Co. raised its price target from $482.00 to $490.00, maintaining an Overweight rating.
Banco Bradesco (BBD) — Itau BBA Securities downgraded the stock to Market Perform.
Best Buy (BBY) — Telsey Advisory Group raised its price target from $95.00 to $110.00, maintaining an Outperform rating.
KE (BEKE) — Citigroup maintained its Buy rating.
KE (BEKE) — Jefferies Financial Group maintained its Buy rating.
BILL (BILL) — William Blair upgraded the stock to Outperform.
Bullish (BLSH) — Wells Fargo & Company lowered its price target from $35.00 to $28.00, maintaining an Equal Weight rating.
Belite Bio (BLTE) — Mizuho raised its price target from $221.00 to $230.00, maintaining an Outperform rating.
Belite Bio (BLTE) — Canaccord Genuity Group raised its price target from $303.00 to $314.00, maintaining a Buy rating.
Benitec Biopharma (BNTC) — Leerink Partners raised its price target from $18.00 to $18.27, maintaining an Outperform rating.
Benitec Biopharma (BNTC) — Wedbush raised its price target from $17.00 to $20.00, maintaining an Outperform rating.
BOX (BOX) — Citigroup raised its price target from $40.00 to $55.00, maintaining a Buy rating.
BP (BP) — Argus raised its price target from $50.00 to $53.00, maintaining a Buy rating.
Bragg Gaming Group (BRAG) — ATB Cormark Capital Markets downgraded the stock to Hold.
Brown & Brown (BRO) — Morgan Stanley raised its price target from $55.00 to $60.00, maintaining an Underweight rating.
Bending Spoons (BSP) — Bank of America set a price target of $38.00, maintaining an Underperform rating.
Bit Digital (BTBT) — B. Riley Financial issued a price target of $3.50, maintaining a Buy rating.
Peabody Energy (BTU) — UBS Group upgraded the stock to Buy and revised its price target from $27.50 to $22.00.
Burlington Stores (BURL) — Morgan Stanley lowered its price target from $432.00 to $381.00, maintaining an Overweight rating.
BrightView (BV) — Oppenheimer lowered its price target from $16.00 to $13.00, maintaining an Outperform rating.
KANZHUN (BZ) — JPMorgan Chase & Co. lowered its price target from $22.00 to $18.00, maintaining an Overweight rating.
Candel Therapeutics (CADL) — Citigroup lowered its price target from $26.00 to $20.00, maintaining a Buy rating.
Chubb (CB) — Morgan Stanley raised its price target from $360.00 to $380.00, maintaining an Equal Weight rating.
CBRE Group (CBRE) — Barclays lowered its price target from $183.00 to $161.00, maintaining an Overweight rating.
Cogent Communications (CCOI) — Wells Fargo & Company downgraded the stock to Underweight and revised its price target from $14.00 to $4.00.
Cardinal Infrastructure Group (CDNL) — Stifel Nicolaus downgraded the stock to Hold and revised its price target from $34.00 to $8.00.
COPT Defense Properties (CDP) — Wells Fargo & Company lowered its price target from $41.00 to $36.00, maintaining an Overweight rating.
CDW (CDW) — Barclays raised its price target from $148.00 to $164.00, maintaining an Equal Weight rating.
Codexis (CDXS) — Stephens maintained its Overweight rating with a price target of $5.00.
Ceva (CEVA) — Cfra upgraded the stock to Buy.
Citizens Financial Group (CFG) — Cantor Fitzgerald raised its price target from $78.00 to $80.00, maintaining an Overweight rating.
Cognex (CGNX) — Barclays lowered its price target from $85.00 to $76.00, maintaining an Overweight rating.
Cummins (CMI) — Morgan Stanley lowered its price target from $761.00 to $588.00, maintaining an Overweight rating.
Cannae (CNNE) — Royal Bank Of Canada downgraded the stock to Sector Perform and revised its price target from $17.00 to $18.00.
Compass Diversified (CODI) — Raymond James Financial maintained its Market Perform rating.
Collegium Pharmaceutical (COLL) — Barclays lowered its price target from $48.00 to $41.00, maintaining an Overweight rating.
Concentra Group Holdings Parent (CON) — Truist Financial maintained its Buy rating and revised its price target from $42.00 to $50.00.
Costco Wholesale (COST) — Northcoast Research downgraded the stock to Neutral.
Copart (CPRT) — Stephens maintained its Equal Weight rating with a price target of $35.00.
Salesforce (CRM) — UBS Group maintained its Buy rating.
Corsair Gaming (CRSR) — Wedbush raised its price target from $16.00 to $17.00, maintaining an Outperform rating.
CareTrust REIT (CTRE) — Mizuho lowered its price target from $45.00 to $44.00, maintaining an Outperform rating.
CareTrust REIT (CTRE) — Wells Fargo & Company raised its price target from $43.00 to $44.00, maintaining an Overweight rating.
CareTrust REIT (CTRE) — KeyCorp lowered its price target from $46.00 to $43.00, maintaining an Overweight rating.
CareTrust REIT (CTRE) — Citizens Jmp maintained its Market Outperform rating with a price target of $44.00.
Corteva (CTVA) — KeyCorp lowered its price target from $17.00 to $14.00, maintaining an Overweight rating.
City Therapeutics (CTY) — Jefferies Financial Group initiated coverage with a Strong-Buy rating.
Cousins Properties (CUZ) — Wells Fargo & Company raised its price target from $34.00 to $35.00, maintaining an Overweight rating.
CVR Energy (CVI) — Mizuho upgraded the stock to Neutral, with a price target of $47.00.
CommVault Systems (CVLT) — DA Davidson maintained its Buy rating with a price target of $210.00.
CommVault Systems (CVLT) — Stephens maintained its Overweight rating with a price target of $205.00.
CVS Health (CVS) — Royal Bank Of Canada lowered its price target from $113.00 to $108.00, maintaining an Outperform rating.
Cushman & Wakefield (CWK) — Barclays lowered its price target from $16.00 to $15.00, maintaining an Equal Weight rating.
Deere & Company (DE) — Raymond James Financial maintained its Outperform rating.
DeFi Technologies (DEFT) — B. Riley Financial maintained its Buy rating and revised its price target from $0.62 to $0.64.
Dell Technologies (DELL) — Morgan Stanley lowered its price target from $511.00 to $403.00, maintaining an Equal Weight rating.
Dell Technologies (DELL) — Citigroup lowered its price target from $600.00 to $550.00, maintaining a Buy rating.
Dolby Laboratories (DLB) — Rosenblatt Securities lowered its price target from $85.00 to $80.00, maintaining a Buy rating.
DLocal (DLO) — Susquehanna maintained its Positive rating.
Dollar Tree (DLTR) — UBS Group raised its price target from $150.00 to $165.00, maintaining a Buy rating.
Healthpeak Properties (DOC) — Mizuho lowered its price target from $24.00 to $23.00, maintaining an Outperform rating.
Healthpeak Properties (DOC) — Wells Fargo & Company raised its price target from $19.00 to $20.00, maintaining an Equal Weight rating.
DPC (DPC) — Morgan Stanley raised its price target from $43.00 to $47.00, maintaining an Equal Weight rating.
DPC (DPC) — Barclays raised its price target from $49.00 to $50.00, maintaining an Overweight rating.
Devon Energy (DVN) — Raymond James Financial maintained its Strong-Buy rating.
Eagle Point Credit (ECC) — B. Riley Financial lowered its price target from $4.50 to $4.00, maintaining a Buy rating.
Echostar (ECHO) — Citigroup raised its price target from $117.00 to $139.00, maintaining a Buy rating.
Encore Capital Group (ECPG) — Truist Financial downgraded the stock to Hold and revised its price target from $122.00 to $115.00.
Consolidated Edison (ED) — Bank of America set a price target of $106.00, maintaining an Underperform rating.
Equifax (EFX) — Needham & Company LLC raised its price target from $210.00 to $220.00, maintaining a Buy rating.
Equifax (EFX) — Mizuho raised its price target from $185.00 to $212.00, maintaining an Outperform rating.
Enovix (ENVX) — Canaccord Genuity Group issued a price target of $2.50, maintaining a Buy rating.
EOG Resources (EOG) — Citigroup raised its price target from $150.00 to $155.00, maintaining a Neutral rating.
EPR Properties (EPR) — Wells Fargo & Company raised its price target from $56.00 to $62.00, maintaining an Equal Weight rating.
Essential Properties Realty Trust (EPRT) — Wells Fargo & Company raised its price target from $30.00 to $32.00, maintaining an Overweight rating.
Eupraxia Pharmaceuticals (EPRX) — Wedbush maintained its Outperform rating.
Edwards Lifesciences (EW) — Wells Fargo & Company raised its price target from $113.00 to $121.00, maintaining an Overweight rating.
East West Bancorp (EWBC) — Cantor Fitzgerald raised its price target from $146.00 to $148.00, maintaining an Overweight rating.
Expand Energy (EXE) — The Goldman Sachs Group lowered its price target from $117.00 to $103.00, maintaining a Buy rating.
Extra Space Storage (EXR) — Barclays raised its price target from $172.00 to $173.00, maintaining an Overweight rating.
First BanCorp. (FBP) — UBS Group initiated coverage with a Neutral rating and a price target of $27.00.
Four Corners Property Trust (FCPT) — Wells Fargo & Company raised its price target from $22.00 to $23.00, maintaining an Equal Weight rating.
Adherex Technologies (FENC) — B. Riley Financial maintained its Buy rating and revised its price target from $18.00 to $19.00.
First Financial Bankshares (FFIN) — Cantor Fitzgerald lowered its price target from $34.00 to $33.00, maintaining a Neutral rating.
Figure Technology Solutions (FIGR) — Mizuho lowered its price target from $55.00 to $46.00, maintaining an Outperform rating.
Deep Fission (FISN) — ThinkEquity initiated coverage with a Buy rating.
Fiserv (FISV) — Robert W. Baird raised its price target from $70.00 to $85.00, maintaining an Outperform rating.
Fold (FLD) — Cantor Fitzgerald set a price target of $0.70, maintaining an Overweight rating.
FMC (FMC) — KeyCorp downgraded the stock to Sector Weight.
Federal Signal (FSS) — Raymond James Financial set a price target of $140.00, maintaining an Outperform rating.
Sensei Biotherapeutics (FTH) — HC Wainwright maintained its Buy rating with a price target of $60.00.
Sensei Biotherapeutics (FTH) — Needham & Company LLC maintained its Buy rating with a price target of $56.00.
FrontView REIT (FVR) — Wells Fargo & Company raised its price target from $20.00 to $22.00, maintaining an Overweight rating.
First Watch Restaurant Group (FWRG) — DA Davidson maintained its Buy rating with a price target of $17.00.
Gemini Space Station (GEMI) — Mizuho lowered its price target from $7.00 to $6.00, maintaining an Outperform rating.
Gemini Space Station (GEMI) — Rosenblatt Securities lowered its price target from $6.00 to $4.50, maintaining a Buy rating.
Gemini Space Station (GEMI) — Needham & Company LLC lowered its price target from $6.50 to $6.00, maintaining a Buy rating.
Gemini Space Station (GEMI) — The Goldman Sachs Group lowered its price target from $4.25 to $3.75, maintaining a Sell rating.
Gilead Sciences (GILD) — Barclays raised its price target from $145.00 to $160.00, maintaining an Equal Weight rating.
Glaukos (GKOS) — BTIG Research raised its price target from $234.00 to $252.00, maintaining a Buy rating.
Globe Life (GL) — TD Cowen raised its price target from $215.00 to $218.00, maintaining a Buy rating.
Gaming and Leisure Properties (GLPI) — Wells Fargo & Company lowered its price target from $40.00 to $39.00, maintaining an Equal Weight rating.
Galaxy Digital (GLXY) — Piper Sandler lowered its price target from $25.00 to $24.00, maintaining an Overweight rating.
Gold.com (GOLD) — DA Davidson maintained its Buy rating with a price target of $60.00.
Goosehead Insurance (GSHD) — Keefe, Bruyette & Woods lowered its price target from $66.00 to $60.00, maintaining an Outperform rating.
W.W. Grainger (GWW) — Morgan Stanley raised its price target from $1,400.00 to $1,590.00, maintaining an Equal Weight rating.
W.W. Grainger (GWW) — Barclays raised its price target from $1,172.00 to $1,355.00, maintaining an Underweight rating.
Hyatt Hotels (H) — Sanford C. Bernstein raised its price target from $202.00 to $231.00, maintaining an Outperform rating.
Haemonetics (HAE) — Citizens Jmp raised its price target from $115.00 to $144.00, maintaining a Market Outperform rating.
Haemonetics (HAE) — Citigroup maintained its Market Outperform rating.
Halozyme Therapeutics (HALO) — TD Cowen maintained its Buy rating.
Hasbro (HAS) — Wells Fargo & Company raised its price target from $100.00 to $115.00, maintaining an Equal Weight rating.
Hasbro (HAS) — Roth Capital maintained its Buy rating and revised its price target from $125.00 to $136.00.
Hasbro (HAS) — JPMorgan Chase & Co. raised its price target from $111.00 to $145.00, maintaining an Overweight rating.
HawkEye 360 (HAWK) — Morgan Stanley raised its price target from $25.00 to $26.00, maintaining an Overweight rating.
HudBay Minerals (HBM) — Barclays lowered its price target from $32.00 to $31.00, maintaining an Overweight rating.
Home Depot (HD) — Zelman & Associates downgraded the stock to Underperform.
Home Depot (HD) — Citigroup downgraded the stock to Sell.
Herbalife (HLF) — Wells Fargo & Company set a price target of $21.00.
Hilton Worldwide (HLT) — Sanford C. Bernstein raised its price target from $320.00 to $380.00, maintaining a Market Perform rating.
HMH (HMH) — Stifel Nicolaus lowered its price target from $28.00 to $25.00, maintaining a Buy rating.
HMH (HMH) — Citigroup maintained its Buy rating.
Hewlett Packard Enterprise (HPE) — Citigroup lowered its price target from $92.00 to $80.00, maintaining a Buy rating.
Hewlett Packard Enterprise (HPE) — Morgan Stanley lowered its price target from $72.00 to $64.00, maintaining an Overweight rating.
HP (HPQ) — Morgan Stanley raised its price target from $19.00 to $21.00, maintaining an Underweight rating.
Healthcare Realty Trust (HR) — Wells Fargo & Company raised its price target from $18.00 to $19.00, maintaining an Equal Weight rating.
Humana (HUM) — Royal Bank Of Canada upgraded the stock to Outperform and revised its price target from $415.00 to $563.00.
Humana (HUM) — Wells Fargo & Company downgraded the stock to Underweight.
Humana (HUM) — William Blair initiated coverage with an Outperform rating.
Humana (HUM) — Cantor Fitzgerald initiated coverage with an Overweight rating.
Humana (HUM) — ThinkEquity initiated coverage with a Buy rating.
Humana (HUM) — TD Cowen upgraded the stock to Buy.
Humana (HUM) — KeyCorp downgraded the stock to Sector Weight.
Hut 8 (HUT) — Piper Sandler lowered its price target from $123.00 to $115.00, maintaining an Overweight rating.
Hancock Whitney (HWC) — Keefe, Bruyette & Woods lowered its price target from $79.00 to $72.00, maintaining a Market Perform rating.
Installed Building Products (IBP) — Truist Financial raised its price target from $180.00 to $220.00, maintaining a Hold rating.
Installed Building Products (IBP) — Royal Bank Of Canada raised its price target from $194.00 to $215.00, maintaining a Sector Perform rating.
Intercontinental Exchange (ICE) — Argus raised its price target from $187.00 to $198.00, maintaining a Buy rating.
Intercontinental Hotels Group (IHG) — Sanford C. Bernstein raised its price target from $154.00 to $177.00, maintaining a Market Perform rating.
Illumina (ILMN) — Jefferies Financial Group set a price target of $235.00, maintaining a Hold rating.
Immunocore (IMCR) — BTIG Research maintained its Buy rating.
Immix Biopharma (IMMX) — HC Wainwright raised its price target from $25.00 to $27.00, maintaining a Buy rating.
Inhibrx Biosciences (INBX) — HC Wainwright lowered its price target from $245.00 to $220.00, maintaining a Buy rating.
Inter & Co. Inc. (INTR) — The Goldman Sachs Group lowered its price target from $9.00 to $8.00, maintaining a Buy rating.
Innoviz Technologies (INVZ) — The Goldman Sachs Group lowered its price target from $0.40 to $0.20, maintaining a Neutral rating.
Samsara (IOT) — Truist Financial lowered its price target from $48.00 to $41.00, maintaining a Hold rating.
iQIYI (IQ) — Jefferies Financial Group set a price target of $1.19, maintaining a Buy rating.
Ingersoll Rand (IR) — Melius Research upgraded the stock to Buy, with a price target of $113.00.
Quince Therapeutics (IRLA) — Citizens Jmp raised its price target from $77.00 to $86.00, maintaining a Market Outperform rating.
Itau Unibanco (ITUB) — JPMorgan Chase & Co. lowered its price target from $10.00 to $9.00, maintaining an Overweight rating.
Invivyd (IVVD) — BTIG Research maintained its Buy rating.
Janus Living (JAN) — Wells Fargo & Company raised its price target from $34.00 to $36.00, maintaining an Overweight rating.
Jade Biosciences (JBIO) — BTIG Research maintained its Buy rating.
Jade Biosciences (JBIO) — Guggenheim lowered its price target from $47.00 to $41.00, maintaining a Buy rating.
Jefferson Capital (JCAP) — Keefe, Bruyette & Woods raised its price target from $30.00 to $32.00, maintaining an Outperform rating.
Jones Lang LaSalle (JLL) — Barclays raised its price target from $401.00 to $404.00, maintaining an Equal Weight rating.
Kraft Heinz (KHC) — Barclays lowered its price target from $25.00 to $24.00, maintaining an Equal Weight rating.
KinderCare Learning Companies (KLC) — Barclays lowered its price target from $3.00 to $1.50, maintaining an Underweight rating.
Kennametal (KMT) — Morgan Stanley lowered its price target from $27.00 to $20.00, maintaining an Underweight rating.
Kinsale Capital Group (KNSL) — Morgan Stanley raised its price target from $350.00 to $400.00, maintaining an Equal Weight rating.
Kinetik (KNTK) — Wolfe Research upgraded the stock to Outperform.
Kinetik (KNTK) — Royal Bank Of Canada raised its price target from $58.00 to $62.00, maintaining an Outperform rating.
Coca Cola FEMSA (KOF) — Itau BBA Securities upgraded the stock to Strong-Buy.
Katapult (KPLT) — Stephens upgraded the stock to Overweight, with a price target of $15.00.
Kura Sushi USA (KRUS) — Northcoast Research downgraded the stock to Neutral.
Centrus Energy (LEU) — Cantor Fitzgerald initiated coverage with an Overweight rating and a price target of $130.00.
Lineage (LINE) — Truist Financial lowered its price target from $46.00 to $41.00, maintaining a Buy rating.
Lakefront Biotherapeutics American Depositary Shares (LKFT) — Morgan Stanley raised its price target from $26.00 to $27.00, maintaining an Equal Weight rating.
Eli Lilly and Company (LLY) — Barclays raised its price target from $1,400.00 to $1,550.00, maintaining an Overweight rating.
Lemonade (LMND) — Morgan Stanley lowered its price target from $48.00 to $45.00, maintaining an Equal Weight rating.
Lowe’s Companies (LOW) — Zelman & Associates downgraded the stock to Underperform.
Larimar Therapeutics (LRMR) — Wedbush lowered its price target from $11.00 to $9.00, maintaining an Outperform rating.
Intuitive Machines (LUNR) — Canaccord Genuity Group lowered its price target from $39.00 to $38.00, maintaining a Buy rating.
LiveOne (LVO) — Freedom Broker lowered its price target from $7.00 to $5.00, maintaining a Buy rating.
Lexeo Therapeutics (LXEO) — Raymond James Financial maintained its Strong-Buy rating.
Marriott International (MAR) — Sanford C. Bernstein raised its price target from $445.00 to $479.00, maintaining an Outperform rating.
MARA (MARA) — Piper Sandler lowered its price target from $11.00 to $10.00, maintaining an Overweight rating.
Mobility Global (MBGL) — Citigroup raised its price target from $23.00 to $25.00, maintaining a Neutral rating.
MercadoLibre (MELI) — Susquehanna maintained its Positive rating.
Milestone Pharmaceuticals (MIST) — Piper Sandler issued a price target of $3.00, maintaining an Overweight rating.
Martin Marietta Materials (MLM) — Morgan Stanley lowered its price target from $639.00 to $590.00, maintaining an Overweight rating.
3M (MMM) — Wells Fargo & Company raised its price target from $195.00 to $205.00, maintaining an Equal Weight rating.
Merit Medical Systems (MMSI) — Raymond James Financial set a price target of $104.00, maintaining an Outperform rating.
Monopar Therapeutics (MNPR) — Morgan Stanley raised its price target from $130.00 to $133.00, maintaining an Overweight rating.
Marsh & McLennan Companies (MRSH) — Morgan Stanley raised its price target from $190.00 to $215.00, maintaining an Equal Weight rating.
MSC Income Fund (MSIF) — Keefe, Bruyette & Woods lowered its price target from $15.50 to $15.00, maintaining an Outperform rating.
MasTec (MTZ) — Guggenheim lowered its price target from $518.00 to $335.00, maintaining a Buy rating.
SOLV Energy (MWH) — TD Cowen raised its price target from $35.00 to $37.00, maintaining a Buy rating.
KindlyMD (NAKA) — B. Riley Financial lowered its price target from $13.00 to $10.00, maintaining a Buy rating.
Navan (NAVN) — TD Cowen raised its price target from $30.00 to $32.00, maintaining a Buy rating.
National Bank (NBHC) — Hovde Group initiated coverage with an Outperform rating and a price target of $42.00.
Nebius Group (NBIS) — Citigroup lowered its price target from $265.00 to $215.00, maintaining a Buy rating.
National CineMedia (NCMI) — B. Riley Financial upgraded the stock to Buy and revised its price target from $2.50 to $3.00.
National CineMedia (NCMI) — National Bank Financial set a price target of $3.00.
NextDecade (NEXT) — TD Cowen raised its price target from $7.00 to $7.50, maintaining a Hold rating.
National Health Investors (NHI) — Wells Fargo & Company lowered its price target from $68.00 to $65.00, maintaining an Equal Weight rating.
NIQ Global Intelligence (NIQ) — Citigroup raised its price target from $16.00 to $19.50, maintaining a Neutral rating.
NIKE (NKE) — Cantor Fitzgerald maintained its Neutral rating with a price target of $38.00.
Nektar Therapeutics (NKTR) — Canaccord Genuity Group lowered its price target from $153.00 to $149.00, maintaining a Buy rating.
Newmark Group (NMRK) — Barclays lowered its price target from $20.00 to $14.00, maintaining an Overweight rating.
NNN REIT (NNN) — Wells Fargo & Company lowered its price target from $43.00 to $42.00, maintaining an Equal Weight rating.
Northrop Grumman (NOC) — BTIG Research maintained its Buy rating.
NeuroPace (NPCE) — Wolfe Research downgraded the stock to Hold.
NeuroPace (NPCE) — Mizuho lowered its price target from $22.00 to $12.00, maintaining an Outperform rating.
NeuroPace (NPCE) — HC Wainwright lowered its price target from $20.00 to $12.00, maintaining a Buy rating.
NRG Energy (NRG) — BMO Capital Markets lowered its price target from $147.00 to $124.00, maintaining a Market Perform rating.
Insperity (NSP) — JPMorgan Chase & Co. raised its price target from $38.00 to $45.00, maintaining an Underweight rating.
NetApp (NTAP) — Evercore maintained its Outperform rating.
Netskope (NTSK) — TD Cowen raised its price target from $19.00 to $25.00, maintaining a Buy rating.
NETSTREIT (NTST) — Wells Fargo & Company raised its price target from $20.00 to $21.00, maintaining an Overweight rating.
Nucor (NUE) — UBS Group upgraded the stock to Buy and revised its price target from $256.00 to $307.00.
NVIDIA (NVDA) — Mizuho lowered its price target from $250.00 to $220.00, maintaining an Outperform rating.
NVIDIA (NVDA) — TD Cowen lowered its price target from $275.00 to $200.00, maintaining a Buy rating.
NVIDIA (NVDA) — UBS Group set a price target of $240.00, maintaining a Buy rating.
NVIDIA (NVDA) — CLSA initiated coverage with a Moderate Buy rating.
NVIDIA (NVDA) — CLSA set a price target of $255.00, maintaining an Outperform rating.
Realty Income (O) — Wells Fargo & Company raised its price target from $59.00 to $61.00, maintaining an Equal Weight rating.
OFG Bancorp (OFG) — UBS Group initiated coverage with a Sell rating and a price target of $50.00.
Once Upon A Farm (OFRM) — Barclays lowered its price target from $19.00 to $11.00, maintaining an Equal Weight rating.
Omega Healthcare Investors (OHI) — Royal Bank Of Canada raised its price target from $51.00 to $52.00, maintaining a Sector Perform rating.
Omega Healthcare Investors (OHI) — Mizuho raised its price target from $46.00 to $49.00, maintaining a Neutral rating.
Omega Healthcare Investors (OHI) — Wells Fargo & Company raised its price target from $46.00 to $49.00, maintaining an Equal Weight rating.
Orion180 Insurance Group (OIG) — Raymond James Financial maintained its Market Perform rating.
Omada Health (OMDA) — JPMorgan Chase & Co. lowered its price target from $30.00 to $25.00, maintaining an Overweight rating.
Ondas (ONDS) — Stifel Nicolaus lowered its price target from $18.00 to $15.00, maintaining a Buy rating.
Orrstown Financial Services (ORRF) — Raymond James Financial maintained its Market Perform rating.
Blue Owl Technology Finance (OTF) — Keefe, Bruyette & Woods lowered its price target from $12.00 to $11.50, maintaining a Market Perform rating.
Ovintiv (OVV) — JPMorgan Chase & Co. set a price target of $84.00.
Blue Owl Capital (OWL) — Mizuho initiated coverage with an Outperform rating and a price target of $13.00.
Owlet (OWLT) — TD Cowen lowered its price target from $10.00 to $4.00, maintaining a Buy rating.
Everpure (P) — Morgan Stanley raised its price target from $137.00 to $142.00, maintaining an Overweight rating.
Everpure (P) — Wedbush set a price target of $130.00, maintaining an Outperform rating.
PACS Group (PACS) — Royal Bank Of Canada raised its price target from $57.00 to $64.00, maintaining an Outperform rating.
Palo Alto Networks (PANW) — Cantor Fitzgerald maintained its Overweight rating with a price target of $425.00.
Palo Alto Networks (PANW) — TD Cowen maintained its Buy rating with a price target of $440.00.
Pro-Dex (PDEX) — Ascendiant Capital Markets raised its price target from $74.00 to $80.00, maintaining a Buy rating.
Principal Financial Group (PFG) — UBS Group initiated coverage with a Sell rating and a price target of $50.00.
Precigen (PGEN) — B. Riley Financial maintained its Buy rating and revised its price target from $12.00 to $11.00.
Palantir Technologies (PLTR) — Deutsche Bank set a price target of $248.00.
Palantir Technologies (PLTR) — Barclays set a price target of $248.00.
Palantir Technologies (PLTR) — Phillip Securities upgraded the stock to Strong-Buy.
Praxis Precision Medicines (PRAX) — Guggenheim raised its price target from $800.00 to $1,050.00, maintaining a Buy rating.
Praxis Precision Medicines (PRAX) — Robert W. Baird raised its price target from $514.00 to $568.00, maintaining an Outperform rating.
Prime Medicine (PRME) — HC Wainwright maintained its Buy rating with a price target of $8.00.
Palvella Therapeutics (PVLA) — Leerink Partners initiated coverage with an Outperform rating and a price target of $228.00.
Q2 (QTWO) — JPMorgan Chase & Co. raised its price target from $76.00 to $82.00, maintaining an Overweight rating.
QXO (QXO) — Raymond James Financial set a price target of $21.00, maintaining an Outperform rating.
Roblox (RBLX) — Piper Sandler maintained its Neutral rating with a price target of $52.00.
RideNow Group (RDNW) — DA Davidson lowered its price target from $8.00 to $5.00, maintaining a Neutral rating.
Real REMAX Group (REAX) — Freedom Broker lowered its price target from $40.00 to $25.00, maintaining a Buy rating.
Replimune Group (REPL) — Piper Sandler raised its price target from $14.00 to $27.00, maintaining an Overweight rating.
Rithm Capital (RITM) — Piper Sandler maintained its Overweight rating.
Rivian Automotive (RIVN) — Citigroup lowered its price target from $18.00 to $14.50, maintaining a Neutral rating.
Rivian Automotive (RIVN) — DA Davidson maintained its Neutral rating with a price target of $15.00.
Suncrete (RMIX) — Robert W. Baird lowered its price target from $17.00 to $9.00, maintaining an Outperform rating.
Roivant Sciences (ROIV) — Guggenheim raised its price target from $46.00 to $48.00, maintaining a Buy rating.
Ross Stores (ROST) — Morgan Stanley raised its price target from $234.00 to $235.00, maintaining an Equal Weight rating.
Rapid Micro Biosystems (RPID) — Lake Street Capital downgraded the stock to Hold, with a price target of $0.75.
Revvity (RVTY) — KeyCorp maintained its Overweight rating with a price target of $200.00.
Revvity (RVTY) — JPMorgan Chase & Co. raised its price target from $160.00 to $165.00, maintaining a Neutral rating.
Recursion Pharmaceuticals (RXRX) — JPMorgan Chase & Co. lowered its price target from $10.00 to $7.00, maintaining an Overweight rating.
Ryan Specialty (RYAN) — Morgan Stanley raised its price target from $50.00 to $55.00, maintaining an Overweight rating.
Sana Biotechnology (SANA) — Citigroup issued a price target of $11.00, maintaining a Buy rating.
Sabra Healthcare REIT (SBRA) — Mizuho raised its price target from $21.00 to $22.00, maintaining a Neutral rating.
Sabra Healthcare REIT (SBRA) — Wells Fargo & Company raised its price target from $21.00 to $23.00, maintaining an Overweight rating.
SolarEdge Technologies (SEDG) — Wells Fargo & Company lowered its price target from $36.00 to $26.00, maintaining an Equal Weight rating.
Super Group (SGHC) (SGHC) — Wells Fargo & Company initiated coverage with an Equal Weight rating and a price target of $13.00.
Somnigroup International (SGI) — The Goldman Sachs Group initiated coverage with a Neutral rating and a price target of $72.00.
Sigma Lithium (SGML) — JPMorgan Chase & Co. lowered its price target from $11.00 to $7.00, maintaining an Overweight rating.
SiteOne Landscape Supply (SITE) — Stifel Nicolaus raised its price target from $102.00 to $108.00, maintaining a Hold rating.
J. M. Smucker (SJM) — JPMorgan Chase & Co. raised its price target from $149.00 to $150.00, maintaining an Overweight rating.
Skyward Specialty Insurance Group (SKWD) — TD Cowen raised its price target from $65.00 to $69.00, maintaining a Hold rating.
Summit Therapeutics (SMMT) — Barclays lowered its price target from $20.00 to $18.00, maintaining an Equal Weight rating.
Summit Therapeutics (SMMT) — Citigroup lowered its price target from $43.00 to $42.00, maintaining a Buy rating.
Semtech (SMTC) — UBS Group lowered its price target from $230.00 to $200.00, maintaining a Buy rating.
Semtech (SMTC) — Morgan Stanley lowered its price target from $205.00 to $176.00, maintaining an Equal Weight rating.
Spectrum Brands (SPB) — Wells Fargo & Company raised its price target from $85.00 to $87.00, maintaining an Equal Weight rating.
SpaceX (SPCX) — Royal Bank Of Canada maintained its Outperform rating with a price target of $225.00.
SpaceX (SPCX) — Pivotal Research maintained its Buy rating.
SpaceX (SPCX) — Raymond James Financial maintained its Strong-Buy rating.
SpaceX (SPCX) — Sanford C. Bernstein maintained its Outperform rating.
SpaceX (SPCX) — Piper Sandler maintained its Neutral rating.
SpaceX (SPCX) — The Goldman Sachs Group maintained its Buy rating.
SiriusPoint (SPNT) — Raymond James Financial maintained its Market Perform rating.
SPX Technologies (SPXC) — TD Cowen upgraded the stock to Buy and revised its price target from $225.00 to $200.00.
Stag Industrial (STAG) — Wells Fargo & Company raised its price target from $38.00 to $39.00, maintaining an Equal Weight rating.
Stagwell (STGW) — Stonex Financial upgraded the stock to Strong-Buy.
Stagwell (STGW) — StoneX upgraded the stock to Buy, with a price target of $15.00.
Neuronetics (STIM) — William Blair initiated coverage with an Outperform rating.
Steel Dynamics (STLD) — UBS Group lowered its price target from $276.00 to $257.00, maintaining a Neutral rating.
Stantec (STN) — Stifel Nicolaus downgraded the stock to Hold.
BBB Foods (TBBB) — Itau BBA Securities downgraded the stock to Market Perform, with a price target of $74.00.
Telephone and Data Systems (TDS) — JPMorgan Chase & Co. lowered its price target from $48.00 to $45.00, maintaining an Overweight rating.
Tidewater (TDW) — Barclays lowered its price target from $91.00 to $88.00, maintaining an Equal Weight rating.
Telecom Argentina Stet – France Telecom (TEO) — UBS Group lowered its price target from $16.50 to $15.00, maintaining a Buy rating.
Target (TGT) — Jefferies Financial Group maintained its Buy rating.
Target Hospitality (TH) — Morgan Stanley lowered its price target from $25.00 to $21.00, maintaining an Overweight rating.
Target Hospitality (TH) — Oppenheimer lowered its price target from $27.00 to $22.00, maintaining an Outperform rating.
The Hanover Insurance Group (THG) — Morgan Stanley raised its price target from $235.00 to $250.00, maintaining an Equal Weight rating.
TJX Companies (TJX) — Morgan Stanley lowered its price target from $178.00 to $166.00, maintaining an Overweight rating.
TriNet Group (TNET) — JPMorgan Chase & Co. raised its price target from $50.00 to $55.00, maintaining an Underweight rating.
Targa Resources (TRGP) — Stifel Nicolaus raised its price target from $335.00 to $340.00, maintaining a Buy rating.
Trustmark (TRMK) — Keefe, Bruyette & Woods raised its price target from $50.00 to $54.00, maintaining a Market Perform rating.
TransUnion (TRU) — Mizuho raised its price target from $74.00 to $78.00, maintaining a Neutral rating.
TWFG (TWFG) — Morgan Stanley raised its price target from $31.00 to $32.00, maintaining an Overweight rating.
Twist Bioscience (TWST) — Barclays lowered its price target from $215.00 to $130.00, maintaining an Overweight rating.
Texas Roadhouse (TXRH) — Gordon Haskett upgraded the stock to Buy, with a price target of $220.00.
Travelzoo (TZOO) — Ascendiant Capital Markets lowered its price target from $20.00 to $18.00, maintaining a Buy rating.
United Dominion Realty Trust (UDR) — Zelman & Associates upgraded the stock to Outperform, with a price target of $41.25.
Ulta Beauty (ULTA) — BMO Capital Markets raised its price target from $580.00 to $665.00, maintaining a Market Perform rating.
USA Rare Earth (USAR) — William Blair downgraded the stock to Market Perform.
VersaBank (VBNK) — Roth Capital maintained its Buy rating and revised its price target from $28.00 to $32.00.
Viking (VIK) — Mizuho upgraded the stock to Outperform, with a price target of $120.00.
Telefonica Brasil (VIV) — UBS Group upgraded the stock to Neutral.
Vivmark Residential Common Shares of Beneficial Interest (VMRK) — Royal Bank Of Canada raised its price target from $67.00 to $68.00, maintaining a Sector Perform rating.
Corporacion Inmobiliaria Vesta (VTMX) — UBS Group raised its price target from $43.00 to $47.00, maintaining a Buy rating.
Ventas (VTR) — Mizuho lowered its price target from $104.00 to $101.00, maintaining an Outperform rating.
Ventas (VTR) — Wells Fargo & Company raised its price target from $96.00 to $102.00, maintaining an Overweight rating.
Welltower (WELL) — Wells Fargo & Company raised its price target from $268.00 to $283.00, maintaining an Overweight rating.
Welltower (WELL) — Mizuho raised its price target from $260.00 to $270.00, maintaining an Outperform rating.
Western Midstream Partners (WES) — Wells Fargo & Company raised its price target from $46.00 to $47.00, maintaining an Equal Weight rating.
W.P. Carey (WPC) — Wells Fargo & Company raised its price target from $73.00 to $74.00, maintaining an Overweight rating.
Wise Group (WSE) — JPMorgan Chase & Co. raised its price target from $17.70 to $17.80, maintaining an Overweight rating.
Williams-Sonoma (WSM) — Telsey Advisory Group set a price target of $285.00, maintaining an Outperform rating.
Watsco (WSO) — Morgan Stanley raised its price target from $330.00 to $340.00, maintaining an Equal Weight rating.
Willis Towers Watson Public (WTW) — Morgan Stanley raised its price target from $325.00 to $350.00, maintaining an Equal Weight rating.
WhiteFiber (WYFI) — Cantor Fitzgerald lowered its price target from $36.00 to $24.00, maintaining an Overweight rating.
X-Energy (XE) — Piper Sandler raised its price target from $8.00 to $9.00, maintaining an Underweight rating.
DENTSPLY SIRONA (XRAY) — UBS Group lowered its price target from $17.00 to $13.00, maintaining a Buy rating.
Yarrow Bioscience (YARW) — Jefferies Financial Group set a price target of $40.00, maintaining a Buy rating.
YETI (YETI) — The Goldman Sachs Group downgraded the stock to Neutral and revised its price target from $57.00 to $41.00.
York Space Systems (YSS) — Citigroup lowered its price target from $10.00 to $8.00, maintaining a Buy rating.
York Space Systems (YSS) — Canaccord Genuity Group upgraded the stock to Buy and revised its price target from $13.50 to $9.00.
Zimmer Biomet (ZBH) — BMO Capital Markets lowered its price target from $102.00 to $101.00, maintaining a Market Perform rating.
Zimmer Biomet (ZBH) — Stifel Nicolaus raised its price target from $125.00 to $140.00, maintaining a Buy rating.
Zevra Therapeutics (ZVRA) — Guggenheim lowered its price target from $23.00 to $18.00, maintaining a Buy rating.

STA Research (StockTargetAdvisor.com) is a independent Investment Research company that specializes in stock forecasting and analysis with integrated AI, based on our platform stocktargetadvisor.com, EST 2007.






